Complete Blood Count (CBC) in COVID-19 Patients Attending at Bangladesh Institute of Health Sciences (BIHS) General Hospital, Dhaka, Bangladesh

Khaleda Ferdous

Bangladesh University of Health Sciences (BUHS), Bangladesh.

Md. Ashiqur Rahman *

Novus Clinical Research Services Limited (NCRSL), Bangladesh.

Sadia Islam

Bangladesh Specialized Hospital Limited (BSHL), Bangladesh.

Sadia Tasnim

Bangladesh University of Health Sciences (BUHS), Bangladesh.

Tamima Ferdausi

Bangladesh University of Health Sciences (BUHS), Bangladesh.

Shohanur Rahaman

Diabetic Association of Bangladesh (BADAS), Bangladesh.

Md. Al-Amin Hossen

United Hospital Limited, Bangladesh.

Adiatuj Jahan Rimu

University of South Asia, Bangladesh.

*Author to whom correspondence should be addressed.


Abstract

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the infectious agent that causes Coronavirus Disease 2019 (COVID-19), a contagious illness. The epidemic has continued since it was first discovered in Wuhan, Hubei, China, in December 2019. The WHO estimated that 800 million people worldwide (or one in ten) may have COVID-19 infection on October 5. More than 1.07 million fatalities and 37 million cases have been documented as of October 11, 2020, spanning 188 nations and territories; more than 25.7 million patients have recovered. Fever, coughing, exhaustion, shortness of breath or other breathing issues, and a loss of taste and smell are typical symptoms. Acute respiratory distress syndrome (ARDS), which can be brought on by cytokine storm, multi-organ failure, septic shock, and blood clots, can affect some people while the majority only have moderate symptoms. One to fourteen days may pass during the incubation period. The aim of this study was to observe the Complete blood count in COVID-19 & Non COVID-19 Patients in Bangladesh. A descriptive cross-sectional study was conducted for the study. Data were collected from Bangladesh Institute of Health Sciences (BIHS) General Hospital and Hematology Department of Bangladesh University of Health Sciences (BUHS). A pretested semi-structured questionnaire was used for the data collection. The standard method of diagnosis is by real-time reverse transcription polymerase chain reaction (RT-PCR) from a nasopharyngeal swab. The results showed that, among 100 patients, 50% patient was Covid-19 positive &50% patient was negative. In comparison between Covid-19 positive & negative CBC result showing that Hb% remain almost same, total count is slightly increased in covid-19 positive patient than non-covid-19. RBC are found in Normal range for both positive and negative patients. Platelet count & PCV are lower in Covid-19 positive patient than negative patient. Neutrophil are significantly raised in Covid-19 positive patient. Lymphocytes are significantly decreased in Covid-19 positive patient than negative. In this study males are affected 64% & females are 36% so the ratio between male& female is 3:2. More positive patients were found in the age between 50-70 years & has risk among 40-80 years. According to this study, it can be concluded that there is an association among neutrophil, lymphocyte and other cell status in clinically in COVID-19 & non COVID-19 Patients.

Keywords: COVID-19, CBC, PCV, SARS-CoV-2, RBC


How to Cite

Ferdous, K., Rahman, M. A., Islam, S., Tasnim, S., Ferdausi, T., Rahaman, S., Hossen, M. A.-A., & Rimu, A. J. (2023). Complete Blood Count (CBC) in COVID-19 Patients Attending at Bangladesh Institute of Health Sciences (BIHS) General Hospital, Dhaka, Bangladesh. Journal of Applied Life Sciences International, 26(5), 27–34. https://doi.org/10.9734/jalsi/2023/v26i5616

Downloads

Download data is not yet available.

References

Pozdnyakova O, Connell NT, Battinelli EM, Connors JM, Fell G, Kim AS. Clinical signi ficance of CBC and WBC morphology in the diagnosis and clinical course of COVID-19 infection, American Journal of Clinical Pathology. 2021;155(3):364– 375.

Xie J, Tong Z, Guan X, Du B, Qiu H. Clinical characteristics of patients who died of coronavirus disease 2019 in China, JAMA Network Open. 2020;3(4).

Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Annals of Hematology. 2020;99(6)1205–1208,

Islam MT, Talukder AK, Badruzzaman M, Khan MAHNA. Health service facilities are positively linked with outcome of COVID-19 patients in majority of the countries: The global situation. J Adv Biotechnol Exp Ther. 2020;3:36–41. Crossref.

Paul R. Bangladesh confirms its first three cases of coronavirus; 2020.

Available:https://www.reuters.com/article/us-health-coronavirus-bangladesh idUSKBN20V0FS

Institute of Epidemiology Disease Control and Research (IEDCR). Bangladesh Covid-19 update; 2020.

Available:https://www.iedcr.gov.bd/

Alam D, Razi A. Why Dhaka's liveability is only worsening; 2018.

Available:https://www.thedailystar.net/supplements/unpacking-2017/why-dhakas-liveability-only-worsening-1512988

Muhammad F, Chowdhury M, Arifuzzaman M, et al. Public health problems in Bangladesh: Issues and challenges. South East Asia J Pub Healt. 2016;6:11–6. Crossref.

Fan BE. Hematologic parameters in patients with COVID-19 infection: A reply. American journal of hematology. 2020

Gao Y, Li T, Han M, Li X, Wu D, Xu Y, Wang L. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. Journal of Medical Virology. 2020;92(7):791-796.

Khartabil TA, Russcher H, van der Ven A, De Rijke YB. A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients. Critical reviews in clinical laboratory sciences. 2020;57(6):415-431.

Rodriguez-Morales AJ, Cardona-Ospina, JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, Sah R. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Medicine and Infectious Disease. 2020; 34:101623.

Siordia Jr JA. Epidemiology and clinical features of COVID-19: A review of current literature. Journal of Clinical Virology. 2020;127:104357.

Usul E, San I, Bekgoz B, Sahin A. Role of hematological parameters in COVID-19 patients in the emergency room, Biomarkers in Medicine. 2020;14(13): 1207–1215.

Yuan X, Huang W, Ye B et al. Changes of hematological and immunological parameters in COVID-19 patients. International Journal of Hematology. 2020; 112(4)553–559,.

Berzuini A, Bianco C, Migliorini AC, Maggioni M, Valenti L, Prati D. Red blood cell morphology in patients with COVID-19-related anaemia. Blood Transfusion. 2021; 19(1):34–36.

Mei Y, Weinberg SE, Zhao L et al, Risk strati fication of hospitalized COVID-19 patients through comparative studies of laboratory results with in fluenza. E Clinical Medicine. 2020; 26.

Rossato M, Di Vincenzo A. Cigarette smoking and COVID-19, Pulmonology. 2021;27(3):277-278.

Fan BE. Hematologic parameters in patients with COVID-19 infection: A reply, American Journal of Hematology. 2020; 95(8).

Lee JJ, Montazerin SM, Jamil A et al., Association between red blood cell distribution width and mortality and severity among patients with COVID-19: A systematic review and meta-analysis, Journal of Medical Virology. 2021;93(4): 2513–2522.

Wang C, Deng R, Gou L, et al., Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters. Annals of Translational Medicine. 2020;8(9):593.